FOLH1 and metastatic malignant neoplasm in the lymph nodes: Recently, PSMA-PET has shown promising effectiveness in detecting metastasis missed by conventional imaging, such as pelvic lymph node metastases (42%) and bone metastases (15%) [55, 56].